A clinical pharmacology study of S-888711 in thrombocytopenic patients with Child-Pugh class C liver disease
Phase of Trial: Phase I/II
Latest Information Update: 22 Nov 2017
At a glance
- Drugs Lusutrombopag (Primary)
- Indications Thrombocytopenia
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- Sponsors Shionogi
- 14 Nov 2017 Status changed from active, no longer recruiting to completed.
- 21 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 20 Jun 2016 New trial record